AMED vs AAPL: Which Stock is Better?
Side-by-side comparison of Amedisys Inc and Apple Inc in 2026
AMED
Amedisys Inc
—
AAPL
Apple Inc
$258.74
Key Metrics Comparison
| Metric | AMED | AAPL | Winner |
|---|---|---|---|
| Market Cap | $3.32B | N/A | AMED |
| P/E Ratio | 39.30 | 32.80 | AAPL |
| EPS (TTM) | $2.57 | $7.89 | AAPL |
| Revenue Growth | 0.1% | 0.2% | AAPL |
| Gross Margin | 43.2% | 47.3% | AAPL |
Analyze AMED
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AMED or AAPL a better investment?
Comparing AMED and AAPL: Amedisys Inc has a market cap of $3.32B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AMED and AAPL?
AMED (Amedisys Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AMED or AAPL?
Based on P/E ratios, AAPL trades at a lower multiple (32.8x vs 39.3x).
Which is growing faster: AMED or AAPL?
AAPL has higher revenue growth at 0.2% vs 0.1% for AMED.
Which company is more profitable: AMED or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to 43.2% for AMED.
Which is the larger company: AMED or AAPL?
Amedisys Inc (AMED) is larger with a market cap of $3.32B compared to N/A for AAPL.
Should I buy AMED or AAPL in 2026?
Both AMED and AAPL have investment merit. AMED trades at $N/A while AAPL trades at $258.74. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AMED and AAPL stock?
Key differences: Market Cap ($3.32B vs N/A), P/E Ratio (39.3x vs 32.8x), Revenue Growth (0.1% vs 0.2%), Gross Margin (43.2% vs 47.3%).